| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,640 | 0,670 | 11:59 | |
| 0,645 | 0,670 | 12:01 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.10. | YIDU TECH (02158): VOLUNTARY ANNOUNCEMENT - TOTAL RETURN SWAP | - | HKEx | ||
| 22.10. | YIDU TECH (02158): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 17.10. | YIDU TECH (02158): NEXT DAY DISCLOSURE RETURNS | 1 | HKEx | ||
| 13.10. | YIDU TECH (02158): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 26.09. | YIDU TECH (02158): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 23.09. | YIDU TECH (02158): VOLUNTARY ANNOUNCEMENT - SUCCESSFUL BIDDING FOR PHASE III CLINICAL STUDY PROJECT OF RECOMBINANT HUMAN NEUROGENESIS FACTOR (SMR001) ... | 1 | HKEx | ||
| 29.08. | YIDU TECH (02158): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, AUGUST 29, 2025 | - | HKEx | ||
| YIDU TECH Aktie jetzt für 0€ handeln | |||||
| 25.07. | YIDU TECH (02158): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED HOLDERS | 1 | HKEx | ||
| 25.07. | YIDU TECH (02158): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS | 1 | HKEx | ||
| 25.07. | YIDU TECH (02158): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, AUGUST 29, 2025 | - | HKEx | ||
| 25.07. | YIDU TECH (02158): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 25.07. | YIDU TECH (02158): NOTICE OF ANNUAL GENERAL MEETING AND PROPOSALS FOR (1) GENERAL MANDATES TO ISSUE SHARES AND SELL AND/OR TRANSFER TREASURY SHARES AND ... | 1 | HKEx | ||
| 25.07. | YIDU TECH (02158): 2025 ANNUAL REPORT | 1 | HKEx | ||
| 30.06. | YIDU TECH (02158): GRANT OF SHARE AWARDS | 2 | HKEx | ||
| 27.06. | Yidu Tech's AI Agents Now Handle 20% of Hospital Tasks: Human-Machine Collaboration Model Showcased at Summer Davos | 332 | PR Newswire | TIANJIN, China, June 27, 2025 /PRNewswire/ -- From June 24 to 26, the World Economic Forum 2025 Annual Meeting of the New Champions was held in Tianjin. Artificial intelligence, as the new... ► Artikel lesen | |
| 25.06. | YIDU TECH (02158): ANNUAL RESULTS ANNOUNCEMENT FOR THE FISCAL YEAR ENDED 31 MARCH 2025 | 2 | HKEx | ||
| 13.06. | YIDU TECH (02158): NOTICE OF BOARD MEETING | - | HKEx | ||
| 11.06. | YIDU TECH (02158): VOLUNTARY ANNOUNCEMENT - SUCCESSFUL BIDDING OF INFORMATION CONSTRUCTION PROJECT FOR THE PHASE II EXPANSION OF BEIJING HUILONGGUAN HOSPITAL | 1 | HKEx | ||
| 05.06. | YIDU TECH (02158): DISCLOSEABLE TRANSACTIONS SUBSCRIPTION OF TREASURY MANAGEMENT PRODUCTS | 1 | HKEx | ||
| 24.01. | Yidu Tech Inc.: Winter Davos 2025: Yidu Tech Accelerates Global Expansion of AI-Powered Healthcare Solutions | 420 | PR Newswire | DAVOS, Switzerland, Jan. 24, 2025 /PRNewswire/ -- From January 20 to 24, the World Economic Forum Annual Meeting 2025, also known as Winter Davos, brought together global leaders in Davos... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,520 | -1,00 % | DEUTSCHE BANK RESEARCH stuft Fresenius SE auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Fresenius von 52 auf 53 Euro angehoben und die Einstufung auf "Buy" belassen. Die anstehenden Quartalszahlen des Medizinkonzerns... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,730 | +0,33 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,870 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,430 | -0,28 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 33,040 | 0,00 % | BrightSpring Health Services GAAP EPS of $0.17 misses by $0.15, revenue of $3.33B misses by $20M | ||
| GERRESHEIMER | 27,240 | -1,30 % | Gerresheimer: Weitere Details - millionenschwere Fehlbuchung | Am Wochenende hat der Spezialverpackungshersteller Gerresheimer per Ad-Hoc-Mitteilung dem Kapitalmarkt weitere Details zur laufenden Prüfung problematischer Buchungen im Konzernbericht für das Fiskaljahr... ► Artikel lesen | |
| UNITEDHEALTH | 295,55 | +0,46 % | Earnings Preview - Teil 1: Make or Break für den Markt: Die Zahlen von UnitedHealth, Microsoft & Alphabet! | © Foto: Richard Drew/AP/dpaDiese in den kommenden Tagen (KW44) anstehenden US-Quartalszahlen müssen Anlegerinnen und Anleger kennen: Herausforderungen, Erwartungen und die aktuell eingepreisten Kursreaktionen... ► Artikel lesen | |
| GENEDX | 137,17 | +4,20 % | GeneDx raises 2025 revenue guidance to $428M amid accelerating exome and genome test growth | ||
| BUTTERFLY NETWORK | 2,695 | 0,00 % | Butterfly Network reaffirms $91M-$95M 2025 revenue target while accelerating AI and chip innovation | ||
| PROCEPT BIOROBOTICS | 34,040 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 44,000 | +0,23 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Carl Zeiss Meditec mit einem Kursziel von 35,10 Euro auf "Underweight" belassen. Vor den am 11. Dezember anstehenden Quartalszahlen lägen seine... ► Artikel lesen | |
| BETA BIONICS | 27,210 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PROGYNY | 18,690 | 0,00 % | Progyny, Inc.: Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause | Global employers can now empower their workforces with comprehensive women's health benefits, supported by localized expertiseNEW YORK, Oct. 22, 2025. (Nasdaq: PGNY), a global leader in women's health... ► Artikel lesen | |
| CLEARPOINT NEURO | 23,230 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,280 | 0,00 % | Privia Health Group, Inc. - 8-K, Current Report |